463 related articles for article (PubMed ID: 33358490)
21. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
[TBL] [Abstract][Full Text] [Related]
22. Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma.
Sakano S; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Kaneda Y; Nasu T; Baba Y; Shimabukuro T; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Oba K;
Int J Clin Oncol; 2015 Apr; 20(2):362-8. PubMed ID: 24964974
[TBL] [Abstract][Full Text] [Related]
23. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
[TBL] [Abstract][Full Text] [Related]
24. The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma.
Li H; Zhou J; Chen R; Zhu J; Wang J; Wen R
Urol Oncol; 2023 Aug; 41(8):356.e1-356.e9. PubMed ID: 37331821
[TBL] [Abstract][Full Text] [Related]
25. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
[TBL] [Abstract][Full Text] [Related]
26. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
27. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
[TBL] [Abstract][Full Text] [Related]
28. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population.
Fang D; Xiong G; Li X; Kang Y; Zhang L; Zhao G; Chen X; Yao L; Zhang X; Yu W; Gong K; Song Y; He Q; He Z; Zhou L; Guo Y
Urol Oncol; 2015 Feb; 33(2):66.e1-11. PubMed ID: 25240760
[TBL] [Abstract][Full Text] [Related]
29. High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy.
Kobayashi Y; Arai H; Hamamoto Y; Yoshida K; Shimizu S; Yasuhara Y; Ichimaru N
Clin Genitourin Cancer; 2023 Oct; 21(5):e386-e393. PubMed ID: 37244798
[TBL] [Abstract][Full Text] [Related]
30. Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma.
Simhan J; Smaldone MC; Egleston BL; Canter D; Sterious SN; Corcoran AT; Ginzburg S; Uzzo RG; Kutikov A
BJU Int; 2014 Aug; 114(2):216-20. PubMed ID: 24053485
[TBL] [Abstract][Full Text] [Related]
31. Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis.
Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Soulières D; Montanari E; Acquati P; Briganti A; Shariat SF; Abdollah F; Carmignani L; Karakiewicz PI
Eur Urol Focus; 2020 Mar; 6(2):298-304. PubMed ID: 30266210
[TBL] [Abstract][Full Text] [Related]
32. Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning.
Liu J; Wu P; Lai S; Wang J; Hou H; Zhang Y
BMC Cancer; 2023 Jun; 23(1):574. PubMed ID: 37349696
[TBL] [Abstract][Full Text] [Related]
33. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
34. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
Urol Oncol; 2017 Jul; 35(7):458.e9-458.e15. PubMed ID: 28347659
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Adjuvant Chemotherapy in Variant Histology Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Stabilized Inverse Probability Treatment Weighting Analysis of Single Center Experience.
Park I; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Ahn H; Cho YM; Lee J; Hong B
Clin Genitourin Cancer; 2024 Jun; 22(3):102069. PubMed ID: 38580522
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.
Liu JY; Dai YB; Zhou FJ; Long Z; Li YH; Xie D; Liu B; Tang J; Tan J; Yao K; He LY
BMC Surg; 2017 Jan; 17(1):8. PubMed ID: 28095848
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.
Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF
Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939
[TBL] [Abstract][Full Text] [Related]
38. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.
Fairey AS; Kassouf W; Estey E; Tanguay S; Rendon R; Bell D; Izawa J; Chin J; Kapoor A; Matsumoto E; Black P; So A; Lattouf JB; Saad F; Drachenberg D; Cagiannos I; Lacombe L; Fradet Y; Jacobsen NE
BJU Int; 2013 Oct; 112(6):791-7. PubMed ID: 23148712
[TBL] [Abstract][Full Text] [Related]
39. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
40. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
